IMPAC leverages management of oncology data

IMPAC Medical Systems Inc. launched Analytiq and Mosaiq at the 46th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) this week in Atlanta.

Mosaiq is IMPAC's next generation image-enabled oncology electronic medical record (EMR) that provides process management for cancer care. The clinical tool can be configured to support computerized physician order entry (CPOE), customizable assessments, document and image management, full DICOM-RT services for PACS implementation, and capabilities to enable adaptive radiotherapy, according to IMPAC.

Analytiq is IMPAC's new line of data aggregation, analysis, and reporting tools. The introductory module of the Analytiq line is Analytiq Practice, a set of visualizations that extract financial and utilization data from IMPAC's practice management system to facilitate analysis of financial performance, productivity, and utilization, IMPAC said.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.